Design and Synthesis of New 1,3,4-Oxadiazole – Benzothiazole and Hydrazone Derivatives as Promising Chemotherapeutic Agents

Abstract

Looking for new cytotoxic and antimicrobial agents with improved antitumor activity, a series of hydrazide and oxadiazole derivatives were designed and synthesized using 3-methoxyphenol as starting substance. Novel N’-(arylidene)-2-(3-methoxyphenoxy)acetohydrazide derivatives (4a–f)/1-(4-substitutedphenyl)-2-[(5-[(3-methoxyphenoxy)methyl]-1,3,4-oxadiazol-2-yl)thio]ethan-1-one derivatives (6a–f)/N-(6-substitutedbenzothiazol-2-yl)-2-[(5-[(3-methoxyphenoxy)methyl]-1,3,4-oxadiazol-2-yl)thio]acetamide derivatives (7a–e) were obtained and evaluated for their in vitro antimicrobial activity against various gram-positive, gram-negative bacteria and fungi. The antimicrobial activity potential of the compounds against gram-negative bacteria was found to have higher compared to the potential against gram-positive bacteria. Also, compounds were screened for their antiproliferative activity against 2 selected human tumor cell lines, A549 lung, MCF7 breast cancer cell line and mouse embryo fibroblast cell line, NIH/3T3 as healthy cell line. Among the compounds evaluated, compound 7c bearing 1,3,4-oxadiazole ring and 6-methoxy benzothiazole moiety exhibited the highest inhibitory activity against A549 and MCF-7 tumor cell lines in contrary to NIH/3T3 cell line, as desired.

Key words

1,3,4-Oxadiazole - benzothiazole - hydrazone - A549 lung cancer cell line - MCF7 breast cancer cell lines - antimicrobial activity

• References

• 1 Caleta I, Kralj M, Marjanovic M. et al. Novel cyano- and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure-activity relationship (QSAR) analysis. J Med Chem 2009; 52: 1744-1756
• 2 http1://www.who.int/mediacentre/factsheets/fs297/en/ (last accessed February 2016)
• 3 CancerStats: Cancer Statistics for the UK. Available at http2://www.cancerresearchuk. org/cancer-info/cancerstats/world/the-global-picture/cancer-overall-world (last accessed February 2016)
• 4 Pisani P. The cancer burden and cancer control in developing countries. Environ Health 2011; 10: S2
• 5 Akbas E, Berber I. Antibacterial and antifungal activities of new pyrazolo[3,4-d] pyridazin derivatives. Eur J Med Chem 2005; 40: 401-405
• 6 Faidallah HM, Rostom SAF, Badr MH. et al. Synthesis of some 1,4,6-trisubstituted-2-oxo-1,2-dihydropyridine-3-carbonitriles and their biological evaluation as cytotoxic and antimicrobial agents. Arch Pharm Chem Life Sci 2015; 348: 824-834
• 7 Aboraia AS, Abdel-Rahman HM, Mahfouz NM. et al. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents. Bioorg Med Chem 2006; 14: 1236-1246
• 8 Khan I, Ibrar A, Abbas N. Oxadiazoles as privileged motifs for promising anticancer leads: recent advances and future prospects. Arch Pharm Chem Life Sci 2014; 347: 1-20
• 9 Rollas S, Kucukguzel SG. Biological activities of hydrazone derivatives. Molecules 2007; 12: 1910-1939
• 10 Andreani A, Burnelli S, Granaiola M. et al. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues. J Med Chem 2008; 51: 809-816
• 11 Yurttaş L, Kaplancıklı ZA, Cantürk Z. et al. Synthesis, antituberculotic and cytotoxic properties of new hydrazone derivatives bearing pyrimidine-alkylsulfanyl moiety. Phosphorus Sulfur Silicon Relat Elem 2015; 190: 1183-1191
• 12 Kumar D, Kumar NM, Ghosh S. et al. Novel is(indolyl)hydrazide-hydrazones as potent anticancer agents. Bioorg Med Chem Lett 2012; 22: 212-215
• 13 Vicini P, Incerti M, Doytchinova IA. et al. Synthesis and antiproliferative activity of benzo[d]isothiazole hydrazones. Eur J Med Chem 2006; 41: 624-632
• 14 Shi DF, Bradshaw TD, Wrigley S. et al. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 1996; 39: 3375-3384
• 15 Caleta I, Grdisa M, Mrvos-Sermek D. et al. Synthesis, crystal structure and antiproliferative evaluation of some new substituted benzothiazoles and styrylbenzothiazoles. Farmaco 2004; 59: 297-305
• 16 Sekar V, Perumal P. Arunachalam et al. Screening of anticancer activity in newly synthesized benzothiazole derivatives. J Pharm Sci Res 2011; 3: 1520-1524
• 17 Szymański P, Zurek E, Mikiciuk-Olasik E. New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer’s disease. Pharmazie 2006; 61: 269-273
• 18 Meena P, Nemaysh V, Khatri M. et al. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer’s disease. Bioorg Med Chem 2015; 23: 1135-1148
• 19 CLSI, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard,CLSI Document M7-A7, seventhed. 2006; ISBN1-56238-587-589
• 20 CLSI, Performance Standards for Antimicrobial Susceptibility Testing 16th Informational Supplement, CLSI document M100-S16. 2006; ISBN1-56238- 588-587
• 21 Hamid R, Rotshteyn Y, Rabadi L. et al. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 2004; 18: 703-710
• 22 Tabbi A, Kaplancıklı ZA, Tebbani D. et al. Synthesis of novel thiazolyl-pyrazoline derivatives and evaluation of their antimicrobial activities and cytotoxicities. Turk J Chem 2016; 40: 641-654